The Effect of Ticagrelor on Acute Coronary Syndrome Patients With Clopidogrel Resistance Undergoing Percutaneous Coronary Intervention
Latest Information Update: 03 Mar 2017
Price :
$35 *
At a glance
- Drugs Clopidogrel (Primary) ; Ticagrelor (Primary)
- Indications Acute coronary syndromes; Thrombosis
- Focus Therapeutic Use
- 21 Feb 2014 Planned End Date changed from 1 Jul 2014 to 1 Jul 2016 as reported by ClinicalTrials.gov record.
- 22 Mar 2013 New trial record